Latest News about NKTR
Recent news which mentions NKTR
Here are the stocks that have soared and sank the most in 2019
October 01, 2019
From MarketWatch
The Daily Biotech Pulse: Enanta Aces Midstage NASH Study, Takeda's Ulcerative Colitis Drug Found Superior To AbbVie's, Decision Day For J&J
September 26, 2019
From Benzinga
80 Biggest Movers From Yesterday
September 11, 2019
From Benzinga
50 Stocks Moving In Tuesday's Mid-Day Session
September 10, 2019
From Benzinga
Here's Why Nektar Therapeutics Plummeted 38% in August
September 04, 2019
From Motley Fool
Here are 2019’s biggest stock market winners and losers in the Dow, S&P 500 and Nasdaq
August 29, 2019
From MarketWatch
The Daily Biotech Pulse: EC Approves Roche's Tecentriq For Breast Cancer, Trevena On Track For NDA Resubmission, Edap Earnings
August 29, 2019
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
August 21, 2019
From Benzinga
The Daily Biotech Pulse: Ra Medical Earns Milestone, Aimmune Doses Patient In Egg Allergy Trial, Cara In-Licenses Platform
August 21, 2019
From Benzinga
76 Biggest Movers From Yesterday
August 13, 2019
From Benzinga
Why Nektar Therapeutics Stock Is Falling Again Today
August 12, 2019
From Motley Fool
54 Stocks Moving In Monday's Mid-Day Session
August 12, 2019
From Benzinga
90 Biggest Movers From Friday
August 12, 2019
From Benzinga
From Motley Fool
75 Stocks Moving In Friday's Mid-Day Session
August 09, 2019
From Benzinga
Large Option Trader Buying Nektar Calls Following Stock Crash
August 09, 2019
From Benzinga
Why Nektar Therapeutics Stock Is Crashing Today
August 09, 2019
From Motley Fool
Nektar Therapeutics Tumbles To 2-Year Low On Q2 Revenue Miss, Manufacturing Issues With Cancer Drug
August 09, 2019
From Benzinga
Benzinga's Top Upgrades, Downgrades For August 9, 2019
August 09, 2019
From Benzinga
31 Healthcare Stocks Moving In Today's Pre-Market Session
August 09, 2019
From Benzinga
10 Biggest Price Target Changes For Friday
August 09, 2019
From Benzinga
52 Stocks Moving In Friday's Pre-Market Session
August 09, 2019
From Benzinga
The Daily Biotech Pulse: Vascepa Delay Sends Amarin Reeling, Eidos Jumps On Buyout Offer, Nektar's Bitter Q2
August 09, 2019
From Benzinga
What You'll Want to Know About Nektar Therapeutics' Q2 Results
August 09, 2019
Tickers
NKTR
From Motley Fool
Nektar Therapeutics (NKTR) Q2 2019 Earnings Call Transcript
August 08, 2019
Tickers
NKTR
From Motley Fool
50 Healthcare Stocks Moving In Thursday's After-Market Session
August 08, 2019
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.